September 15, 2021 | OnDemand

As the GTN bubble grows, so does increased stakeholder scrutiny on GTN analytics. Although the industry is moving toward automating GTN processes, many life sciences manufacturers are not embracing automation at pace with the industry and often face obstacles in achieving their automation goals.

In this informative webinar, Jen Sharpe, GTN lead and facilitator of the Revenue Analytics Collaborative at IntegriChain reviews the results of the recent GTN Automation survey and report, discusses the value of automation, and the best ways to build a business case within the organization.

Topics covered include:

• Who has embraced GTN automation
• How to identify and mitigate barriers to adoption that exist in the industry
• What current or potential risks currently exist around automation
• How to transform risks into successful outcomes

Jen Sharpe